Why Biopharma Prioritize Returning to this Meeting
The 5th Liquid Biopsy for Precision Oncology Summit East Coast will be a hub boasting new ideas, innovations, technologies, advancements and more! But don’t just take our word for it, hear why your peers are keen to join this meeting.
"The summit provided a very strong and focused exchange around ctDNA innovation and MRD evolution. The level of scientific rigor and the openness of discussion around technical limitations, tumor heterogeneity, and real-world implementation challenges were especially valuable"
Chief Executive Officer, Biopsomic
"It is the place where passionate people with a vision of the future meet every year to share their experiences, expertise, ideas and scientific and technological advancements in the liquid biopsy space"
Director, Precision Medicine, AbbVie
"The quality of the sessions was fantastic. There was ample opportunity for Q&A during and after, which meant I left the conference with plenty of actionable ideas"
Chief Scientific Officer, Aveta Biomics
"The in-depth discussions on emerging topics in liquid biopsy and its role in clinical trial design and patient stratification, were both timely and thought-provoking"
Scientific Expert, Harvard Medical School
"I was surprised by the high level of interaction between presenters and the audience. This meeting boasted a very interesting array of actors intervening in the liquid biopsy space"
Director, Biology, Kestrel Therapeutics
"The networking opportunities were truly valuable. Another important aspect that stood out to me was the excellent choice of speakers"
Professor, St. George’s University
"It was great to connect with leading experts in the field and exchange ideas on cutting-edge advancements. It was truly inspiring to see how these technologies are shaping the future of cancer care"
Researcher, Tufts University
"The small conference size allowed for better networking and ensured an engaging experience with KOLs spanning both devices and pharma"
Diagnostics Lead, Alexion Pharmaceuticals
"I really like these smaller, intimate meetings as you have the chance to really connect with people. This meeting’s focused agenda also allowed me to build relationships and connections in this specific area of the field"
Director, Cancer Translational Science, Foundation for the National Institutes of Health
Delve into the Brand-New Agenda
- Find the full speaker faculty, featuring senior leaders from Pfizer, AbbVie, Takeda, AstraZeneca, GSK and more
- Plan your 2026 experience, identify the sessions you cannot miss and map the partners to meet
- Gain exclusive insights into MRD as a regulatory endpoint, ctDNA-driven dose optimization, and AI-integration in precision oncology pipelines
- Unpack the complete details of our in-depth Pre-Conference Engager Sessions and register your interest before spots are filled
Explore the New Agenda
Discover the latest breakthroughs in ctDNA, MRD, methylation and multi-omic profiling through a focused program of expert presentations, interactive roundtables and strategic panel discussions driving precision oncology forward.
Stand at the Forefront of Liquid Biopsy Innovation
Position your solutions alongside leading diagnostic and technology providers to ensure your brand is central to the conversations shaping the next generation of oncology drug development.
Join Senior Biopharma & Diagnostic Leaders
Engage with decision-makers across translational medicine, precision oncology and clinical development, and build high-value connections during dedicated networking sessions designed to foster collaborations.